Strasser R, Klepzig H
MMW Munch Med Wochenschr. 1981 Aug 28;123(35):1303-6.
In a double placebo-controlled, partly single blind and partly double blind ergometric trial, the acute action of acebutolol and nifedipine singly and in combination on cardiovascular parameters and ischemic reactions was studied. Neither nifedipine nor acebutolol lowered the resting heart rate nor the resting blood pressure significantly. At the highest load the heart rate, systolic blood pressure and the pressure-frequency product were significantly reduced, the changes due to acebutolol being more marked than those of nifedipine. nifedipine alone reduced the ST segment by 1/3, acebutolol by a half. The combined administration of acebutolol and nifedipine produced without exception significant reductions of heart rate, blood pressure, pressure-frequency product, ST segment, and ischemic pain as compared with placebo.
在一项双安慰剂对照、部分单盲和部分双盲的测力计试验中,研究了醋丁洛尔和硝苯地平单独及联合使用对心血管参数和缺血反应的急性作用。硝苯地平和醋丁洛尔均未显著降低静息心率和静息血压。在最大负荷时,心率、收缩压和压力-频率乘积显著降低,醋丁洛尔引起的变化比硝苯地平更明显。单独使用硝苯地平使ST段降低1/3,醋丁洛尔使ST段降低一半。与安慰剂相比,醋丁洛尔和硝苯地平联合给药无一例外地显著降低了心率、血压、压力-频率乘积、ST段和缺血性疼痛。